The
Connecticut Neurological Society (CNS) Presents:
The 30th Annual Connecticut Neurology Symposium
Friday, October 3, 2008
8:00 AM
– 4:10
PM
Hartford
Marriott® Downtown
200 Columbus Blvd
Hartford, CT 06103-2807
Phone: 1-866-373-9806
Fax: 1-860-249-8181
General
Information
This activity will include breakfast, lunch, 9 live
lectures, and 4 question and answer sessions. All
participants will receive an activity workbook containing
a copy of the presentation slides. Tuition
is $100 and includes breakfast, lunch, and
refreshments throughout the day. All residents,
students, and trainees are FREE.
Self-parking:
$11; overnight: $18
Valet: $13; overnight:
$20
Needs
Statement
Neurologists manage numerous neurological
disorders such as headache disorders, epilepsy disorders,
neurodegenerative disorders, sleep disorders, cerebral
palsy, infections, neoplasms, movement disorders,
demyelinating diseases, spinal cord disorders, disorders
of the peripheral nerves, and traumatic injuries to
the brain, spinal cord, or nerves. The demand for
neurologists to remain up-to-date in numerous neurological
disorders is great. As a result, the CNS and CMK will
jointly sponsor the 30th Annual Neurology Symposium
to meet the educational needs of neurologists in Connecticut.
Agenda
8:00 AM – Registration/Continental
Breakfast
8:30 – Welcome
– Opening Remarks
Jan Mashman, MD, FAAN
President, Connecticut Neurological
Society
Associated Neurologists P.C.
Danbury, Connecticut
Moderator:
David Greco, MD
8:40 – Existing
& Emerging Treatments in MS
Jana Preiningerova, MD
Assistant Professor & Director, Neuroimmunology
Program
Yale University School of Medicine
New Haven, Connecticut
9:20 – MS
as a Neurodegenerative Disease & the Role of Conventional
& Nonconventional MRI
James Stankiewicz, MD
Associate Neurologist
Brigham and Women’s Hospital
Boston, Massachusetts
10:00 – MS
Question & Answer Session
10:15 – Coffee
Break
10:35 – Review
of Current Therapies for PD
Paula D. Ravin, MD
Associate Professor of Clinical Neurology
University of Massachusetts Memorial Health Care
Worcester, Massachusetts
11:15 – Comorbidity
Concerns with the Patient with PD
Alice W. Flaherty, MD
Director, Movement Disorders Program
Massachusetts General Hospital
Boston, Massachusetts
11:55 – PD
Question & Answer Session
12:10 PM
– Buffet Lunch
1:10 – Advocacy
Update
Anthony Alessi,
MD, MMM
Associate Clinical Professor
Department of Neurology
University of Connecticut Health Center
Norwich, Connecticut
1:25 –
Dementia: Early Detection and the AAN Guidelines
Andrew E. Budson, MD
Associate Professor of Neurology
Director, Cognitive Neuroscience Research, Alzheimer's
Disease Center
Boston University School of Medicine
Boston, Massachusetts
1:55 – What’s
New in Dementia Treatment
Alireza Atri, MD, PhD
Associate Director of the CTCN
Massachusetts General Hospital/Harvard Medical School
Boston, Massachusetts
2:25 – Question
& Answer Session
2:40 – Coffee
Break
3:00 – NeuroRadiology
Presentation
Scott
Berger, MD
Vice Chairman, Medical Director Neuroradiology
Danbury Hospital
Danbury, Connecticut
3:30 – Practice
Management Presentation/AAN Web Site
Orly Avitzur, MD
Instructor, Yale University School of Medicine
New Haven, Connecticut
Assistant Professor, New York Medical College
Valhalla, New York
4:10 – Closing
Remarks/Adjourn
Jan Mashman, MD, FAAN
Target
Audience
The target audience for this activity
is practicing neurologists, nurses, residents, students,
and other healthcare professionals involved in the
management of patients with neurological disorders.
Educational
Objectives
Upon completion of this course, the participants should
be able to:
- List existing and emerging treatments
for multiple sclerosis (MS) and Parkinson’s
disease (PD)
- Recognize MS as a neurodegenerative
disease and discuss the role of conventional and
nonconventional MRIs in its diagnosis
- Identify comorbidity concerns
for the patient with PD
- Review the current American Academy
of Neurology (AAN) guidelines on the detection,
diagnosis, and management of dementia and list current
and emerging treatments
- Discuss the role of neuroradiology
in the neurologist’s practice
Accreditation
Statement
This activity has been
planned and implemented in accordance with the Essential
Areas and policies of the Accreditation Council for
Continuing Medical Education (ACCME) through the joint
sponsorship of the Connecticut Neurological Society
and CMK. CMK is accredited by the ACCME to provide
continuing medical education for physicians.
Credit
Statement
CMK designates this educational activity for a maximum
of 5.75 AMA PRA Category 1 Credit(s)™.
Physicians should only claim credit commensurate with
the extent of their participation in the activity. |
